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Vertebrate poxviruses encode homologs of cellular cupro-zinc superoxide dismutases (Cu-Zn SOD). In this study we have
examined the molecular genetic properties of two Cu-Zn SOD homologs encoded by the Shope fibroma virus (SFV) and
myxoma virus. These Leporipoxvirus proteins should be catalytically inactive as judged by the point mutations which alter
a key catalytic arginine and restructure the predicted Cu-binding domain. This prediction was confirmed using in situ gel
assays and recombinant proteins produced both in bacteria and in mammalian cells. Western blot analysis showed that these
proteins are produced in abundance late in infection and can, upon exposure to oxidizing conditions, form disulfide
cross-linked dimers. They are also virion components and not essential for growth in culture or virulence. Leporipoxvirus
Cu-Zn SOD homologs affected two phenotypes. First, deletion of the myxoma M131R gene caused the mutant virus to grow
better (10-fold) in culture than does the wild-type parent. Second, expression of either native or recombinant Leporipoxvirus
proteins is accompanied by a decline in cellular Cu-Zn SOD activity. We concluded that these gene products can somehow
modulate the activity of host Cu-Zn SODs, but what advantage is thus gained by the virus remains to be established. © 2002INTRODUCTION
It has long been known that poxvirus genomes encode
genes that may play a role in regulating the redox status
of infected cells. Examples of these genes include Or-
thopoxvirus and Leporipoxvirus glutaredoxin homologs,
Molluscipoxvirus and Fowlpoxvirus glutathione peroxi-
dase homologs, and widely distributed viral cupro-zinc
superoxide dismutase homologs (Cu-Zn SOD). Why pox-
viruses encode such genes is still a subject of investi-
gation. Some of these proteins play a role in virus repli-
cation and assembly, while others may protect replicat-
ing viruses from the reactive oxygen species (ROS)
produced endogenously or by phagocytic cells during
the course of viral infection (McFadden, 1998).
Biochemical and genetic investigations have previ-
ously provided insights into the biology of some of these
genes. Vaccinia encodes two glutaredoxin gene ho-
mologs (G4L and O2L) with G4L homologs being widely
distributed among vertebrate poxviruses, while O2L-like
genes are encoded by just vaccinia and variola (Gva-
kharia et al., 1996; Johnson et al., 1991). These proteins
possess thioltransferase and dehydroascorbate reduc-
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3125tase activity and clearly serve different functions (Ahn
and Moss, 1992; Gvakharia et al., 1996). G4L is an es-
sential gene which serves as a redox-shuttle required for
vaccinia virus morphogenesis (White et al., 2000, 2002),
while O2L serves a nonessential role in nucleotide bio-
synthesis (Rajagopal et al., 1995). Molluscum contagio-
sum and fowlpox viruses encode glutathione peroxidase
homologs (MC066L and FPV064, respectively) (Afonso et
al., 2000; Senkevich et al., 1996). The molluscum protein
is a selenoenzyme that can reduce cytotoxic peroxides
and protects transfected cells from ultraviolet light and
hydrogen peroxide (Shisler et al., 1998). However,
MC066L’s biological function remains unclear for lack of
a suitable viral culture system.
A third class of widely distributed, potentially redox
active, poxviral proteins are those homologous to cellular
Cu-Zn SODs. Superoxide dismutases are metalloen-
zymes that catalyze the dismutation of two molecules of
superoxide anion (O2
) into H2O2 and O2 (Fridovich,
1997). Superoxide has potential antiviral activity, because
it is one of several cytotoxic ROS produced by phago-
cytes, although it is the hydrogen peroxide that is actu-
ally the more dangerous toxicant and a powerful apopto-
tic inducer. Poxvirus-encoded homologs of animal Cu-Zn
SOD have been identified in a variety of genomes, in-
cluding the Orthopoxviruses vaccinia (A45R) and variola,Elsevier Science (USA)
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(e.g., AMV255) (Aguado et al., 1992; Bawden et al., 2000;
Blasco et al., 1991; Cameron et al., 1999; Smith et al.,
1991; Willer et al., 1999). Seemingly nonessential and
inactive SOD-like genes of unknown function are also
encoded by baculoviruses (Tomalski et al., 1991) and a
distantly related gene more closely resembling sweet
potato SOD is encoded byMolluscum contagiosum virus
(MC163R) (Senkevich et al., 1997).
Our interest in these genes was sparked by the ob-
servation that the conservation of sequence, between
myxoma virus and Shope fibroma virus (SFV) SOD ho-
mologs, suggested myxSOD and sfvSOD proteins serve
a function retained by selection during the long diver-
gence of these two evolutionarily distinct Leporipoxvi-
ruses. The same sequence conservation characterizes
vaccinia and variola virus SOD homologs, although these
viruses are clearly more recently divergent than are myx-
oma and SFV and the gene sequences have drifted much
further from cellular Cu-Zn SOD than have Leporipoxvi-
rus genes. In a recent publication, Almaza´n and col-
leagues showed that A45R protein is a catalytically in-
active viral core component which is not required for
growth in culture or virulence in mice (Almazan et al.,
2001). The lack of catalytic activity is not surprising given
the in-frame deletions scattered through the gene, but it
is unusual that a poxviral core protein is not required for
growth or virulence. Despite providing important insights
into the molecular genetic properties of A45R, these
studies leave the biological function(s) of these genes
uncertain.
In an effort to address this problem we have investi-
gated the biochemical properties of the more “SOD-like”
proteins encoded by Leporipoxviruses. Our results show
that the lack of catalytic activity is a general property of
these proteins and further show that SFV and myxoma
proteins can inhibit the activity of cellular Cu-Zn SOD.
What advantages are gained by SOD homolog-encoding
viruses nevertheless remains unclear, because viruses
encoding a disrupted gene still replicate normally and
exhibit unaltered virulence in European rabbits.
RESULTS
Structural features of Leporipoxvirus SOD homologs
The S131R and M131R genes of SFV and myxoma
viruses encode 96% identical proteins of masses 17,775
and 17,786 Da, respectively. BLAST searches (Altschul et
al., 1997) readily detected other viral protein homologs as
well as numerous cellular homologs. Figure 1 illustrates
a Macaw alignment of a selection of these proteins
(Schuler et al., 1991), including SOD-like proteins en-
coded by vaccinia and variola viruses, homologs en-
coded by other representative DNA viruses, and also
cytosolic rabbit (Oryctolagus cuniculus) (Reinecke et al.,
1988) and bovine (Bos taurus) Cu-Zn SODs (Steinman et
al., 1974). The crystal structure of the bovine enzyme
(Rypniewski et al., 1995; Tainer et al., 1982) provides
insights into the properties of the homologous viral pro-
teins and illustrates several intriguing features of the
poxvirus proteins. Generally Leporipoxvirus proteins
more closely resemble their cellular homologs than do
Orthopoxvirus proteins, although not as closely as do
other viral proteins. For example, SFV and myxoma pro-
teins retain seven of eight metal coordinating amino
acids, while point mutations and deletions in the variola
and vaccinia genes have clearly eliminated the Zn-bind-
ing site and all but one of the Cu coordinating residues.
Nevertheless the SFV and myxoma proteins would still
be predicted to be catalytically inactive as a result of an
R-to-V substitution at the catalytic site (Fig. 1). An intras-
trand disulfide bond would also be disrupted in the
Leporipoxvirus proteins by a C-to-W substitution near the
protein C-terminus. The Leporipoxvirus proteins have
relatively long N-terminal extensions relative to other
protein homologs, but the presence of a highly con-
served “KAVC” motif immediately upstream of M22 clearly
favors M1 rather than M22 as the translational start site. It
is also noteworthy that the majority of glycines and other
small hydrophobic residues comprising the Cu-Zn SOD
homodimer interface have been retained over the course
of evolution by all of these proteins. Thus myxoma and
SFV SOD homologs should still be capable of forming
homodimers as do cytosolic Cu-Zn SODs.
Recombinational inactivation of myxoma M131R
To determine whether these genes encode an essen-
tial function, we used homologous recombination to con-
struct a mutant virus in which the M131R gene was
entirely replaced by a gpt cassette (Falkner and Moss,
1988) while leaving intact the flanking genes (Fig. 2A).
The PCR was used to confirm the structure of the result-
ing virus, MYX_131R (Fig. 2B). We were unable to detect
any deleterious effect of the mutation upon growth of
MYX_131R in culture. In fact, single-step growth analy-
sis showed that mutant viruses seem to grow better than
do wild-type viruses (Fig. 3). When plated on either rabbit
kidney (RK13) or baby green monkey kidney (BGMK) cells
at a multiplicity of infection of 10, burst sizes were repro-
ducibly 10-fold greater for the mutant virus vs the wild-
type. We concluded that the M131R gene is not essential
for growth of myxoma virus in culture and may, paradox-
ically, inhibit virus production.
Expression of Leporipoxvirus SODs
The S131R and M131R genes both encode 5-TA-
AATG-3 motifs typical of poxviral late promoters. To test
whether these are indeed late gene products, 35S-label-
ing and Western blot analyses were performed. Figure 4
shows an analysis of the 35S-labeled proteins that were
recovered from myxoma-infected cells at various times
following infection in the presence of 35S-labeled cys-
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teine and methionine. An 18-kDa protein was first de-
tected in these extracts about 12 h postinfection, which
then accumulated to high levels by 24 h postinfection
(Fig. 4, top). That this protein is myxSOD was suggested
by the fact that it cannot be detected in mock-infected
cells or in cells infected with the MYX_131R deletion
virus (Fig. 4, top, lanes 1 and 7, respectively). In addition
to these experiments we also performed a Western blot
analysis using a monoclonal antibody raised against
recombinant S131R. This antibody reacts equally well
with both SFV and myxoma proteins and in this experi-
ment first detected the expression of a new 18-kDa
antigen in myxoma-infected cells about 12 h postinfec-
tion. The 18-kDa protein continued to accumulate in
wild-type extracts through 24 h postinfection and was
again not detected in mock- or MYX_131R-infected
cells (Fig. 4, bottom). Analysis of the proteins present in
the culture media surrounding virus-infected cells
showed that these proteins were not secreted (data not
shown). These data show that M131R, and S131R, al-
though not shown, are intracellular proteins expressed
with kinetics typical of Leporipoxvirus late gene prod-
ucts. That these are late gene products was confirmed
by the fact that Ara-C blocks the M131R protein expres-
sion in myxoma-infected BGMK cells (data not shown).
The fact that M131R can be readily detected in cell-
free extracts using 35S-labeling suggested that this is an
abundantly expressed viral protein. To investigate its
subsequent fate, we purified myxoma virus particles us-
ing tartrate gradients and used Western blotting to con-
firm that myxoma virus, similar to vaccinia, incorporates
the protein into virions (data not shown). How much
protein is incorporated by the virus into the virion was
estimated using a combination of semiquantitative West-
ern blotting and virus particle counts. Recombinant sfv-
SOD protein was purified from Escherichia coli (see
below) and cleaved with thrombin, and known amounts
of this protein were Western blotted alongside of pro-
teins extracted from gradient-purified myxoma particles.
Since purification of myxoma inactivates some uncertain
fraction of the virus, and thus creates uncertainties re-
garding the ratio of particle to plaque forming units, we
determined the numbers of virus particles by electron
microscopy rather than by plaque assay (see Materials
and Methods). If it is assumed that the two nearly iden-
tical viral proteins are equally immunoreactive, these
FIG. 1. Multiple sequence alignment illustrating viral and cellular Cu-Zn SOD homologs. Protein sequences were aligned using Macaw (Schuler
et al., 1991) and the figure prepared using Boxshade 3.21 (www.isrec.isb-sib.ch:8080/software). Based upon the crystal structure of bovine Cu-Zn SOD,
the symbols located beneath the consensus sequence indicate the following: E, Cu-binding residues; F, Zn-binding residues; #, intrastrand disulfide
cross-linked cysteines; *, catalytic arginine. GenBank Accession Nos. are SFV (strain Kasza, NP_052020), myxoma virus (strain Lausanne,
NP_051845), variola major virus (strain India-1967, NP_042201), vaccinia virus (strain WR, P26669), PB_CV1 (Paramecium bursaria chlorella virus 1,
NP_048593), AM_EPV (Amsacta moorei entomopoxvirus, NP_065037), AC_NPHV (Autographa californica nucleopolyhedrovirus, NP_054060), PX_GV
(Plutella xylostella granulovirus, NP_067786), rabbit (Oryctolagus cuniculus, P09212), and bovine (Bos taurus, P00442) Cu-Zn SODs.
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experiments suggested that 4.7 107 virions contain2
ng of M131R, or about 1400 protein molecules per parti-
cle. This is admittedly only a crude estimate of the ratio
of protein to particle, but it is still clear that large quan-
tities of protein are incorporated into Leporipoxvirions.
Catalytic activities of Leporipoxvirus SOD homologs
To determine whether these proteins were catalytically
active, we prepared recombinant sfvSOD and assayed
the protein for SOD activity using an in situ gel assay.
The SFV S131R gene was amplified using the PCR and
cloned in two steps in an E. coli pGEX2T expression
vector. A fusion protein was then produced in E. coli
bearing sfvSOD fused to glutathione-S-transferase (GST)
(Smith and Johnson, 1988). The recombinant protein was
affinity purified and cleaved free of the GST domain using
thrombin. The fusion protein was also used to prepare a
mouse monoclonal antibody with the assistance of Dr.
M. Suresh (University of Alberta). After digestion with
thrombin, these protein preparations contained the re-
leased GST domain plus three or four 18-kDa sfvSOD
polypeptides that all reacted with the antibody (data not
shown). The recombinant protein was then subjected to
native gel electrophoresis and assayed for SOD activity
using an in situ gel assay. This assay detects SOD
activity as a clear band on a blue-stained gel, which is a
result of the dismutase interfering in the reduction of
nitroblue tetrazolium to formazan (Beauchamp and Fri-
dovich, 1971). While these assays readily detected less
than 10 ng of bovine SOD, no trace of activity was seen
using up to 2 g of sfvSOD fusion protein (Fig. 5). When
protein purity and mass differences are taken into ac-
count, this result suggested that if sfvSOD does retain
catalytic activity, the dismutase activity is substantially
less than 0.5% of that exhibited by bovine Cu-Zn SOD
under these reaction conditions.
To exclude the possibility that bacterial expression
systems might be incapable of folding or incorporating
metals into the SFV protein, we used in situ gel assays to
screen extracts prepared from cells infected with SFV or
myxoma virus and again found no evidence to suggest
that virus infection induced expression of a novel SOD
activity. We also examined whether active protein could
FIG. 3. Effect of an M131R deletion mutation on virus growth. RK13
and BGMK cells were infected with either wild-type myxoma virus or
MYX_131R deletion mutant virus at a multiplicity of infection of 10.
Virus samples were harvested by freeze-thaw at the indicated times
postinfection, and virus titers were determined on BGMK cell mono-
layers in triplicate.
FIG. 2. Insertional inactivation of myxoma virus M131R. (A) Plasmid
pJXC100 was assembled using the PCR and encodes the E. coli gpt
gene flanked by sequences also flanking the M131R gene. This plas-
mid was transfected into myxoma virus infected cells and recombinant
viruses isolated based upon the resulting resistance to mycophenolic
acid. Flanking genes M130R and M132L are unaffected by this deletion.
(B) PCR analysis of recombinant virus lacking M131R. Primers de-
signed to amplify the M131R open reading frame (lane 2) do not detect
M131R sequences in MYX_131R (lane 4). However, primers targeting
the N-terminal or C-terminal portions of the E. coli gpt gene permit
amplification of sequences encoding the gpt and flanking genes (lanes
6 and 7).
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be produced using a hybrid vaccinia virus/T7 expression
system (Fuerst et al., 1986). Recombinant vaccinia vi-
ruses were constructed encoding the native S131R gene
product under control of a T7 promoter (VMM1.5 and
VMM5.2) and coinfected into cells along with a helper
virus expressing T7 RNA polymerase (VTF7.5). Sufficient
amounts of protein were recovered 24 h postinfection for
it to be easily visible as an 18-kDa protein band on a
Coomassie-stained gel and comprising perhaps 2% of
rabbit corneal fibroblast (SIRC) cell protein extracts (data
not shown). Western blots confirmed the identity of the
protein. However, we still saw no new or enhanced SOD
activity when 60 g of the whole-cell extract was as-
sayed for activity using the dye reduction assay (data not
shown). Endogenous cellular Cu-Zn superoxide dis-
mutase was easily detected under these conditions,
showing that the assay and extraction methods were
working properly. Experiments using myxoma virus and
vaccinia expressed recombinant myxSOD similarly failed
to detect any novel dismutase activities. While it is diffi-
cult to accurately derive a minimal estimate of catalytic
activity using these different alternate experimental ap-
proaches, we found no evidence to suggest the Lepori-
poxviral proteins retain any catalytic capacity as super-
oxide dismutases.
Leporipoxvirus SOD homologs form disulfide cross-
linked dimers
While investigating the properties of these proteins, it
was noted that they exhibited different molecular
weights depending upon whether samples were dena-
FIG. 5. Recombinant sfvSOD does not catalyze superoxide dis-
mutase reactions. The indicated quantities of purified protein were
separated on a 10% native polyacrylamide gel and the gel stained for
SOD activity. This in situ assay readily detected the activity associated
with 10 ng of bovine Cu-Zn SOD (lane 1), but neither the GST-sfvSOD
fusion protein (lane 4) nor thrombin-treated fusion protein (lane 5)
displayed any detectable activity.
FIG. 4. Kinetics of M131R protein expression determined by 35S-
labeling and Western blot analysis. (Top) BGMK cells were infected
with either wild-type myxoma virus or the MYX_131R deletion mutant
virus at a multiplicity of infection of 20. The media was supplemented
with 200 Ci of [35S]cysteine and methionine to label any proteins
synthesized following infection. The cells were washed and harvested
at the times indicated and 80 g of protein loaded per lane using a
loading buffer containing both sodium dodecyl sulfate and -mercap-
toethanol. Autoradiography was used to identify proteins expressed
during virus infection. An 18-kDa protein was first detected in cells
infected with wild-type virus about 12 h postinfection and by 24 h
postinfection it was one of the most abundant labeled molecules in
these extracts. This protein is not seen in cells infected with
MYX_131R. We often noted more labeled virus proteins in samples
extracted from MYX_131R-infected cells at 12 h postinfection. This
may reflect the somewhat better growth of mutant viruses (Fig. 3).
(Bottom) Proteins were extracted from virus-infected BGMK cells at the
indicated times, fractionated using SDS–PAGE, and Western blotted
using a monoclonal antibody raised against recombinant sfvSOD. An
18-kDa late protein is also detected by this method, again only in
cells infected with wild-type virus.
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tured under oxidizing or reducing conditions prior to
electrophoresis. Figure 6 illustrates this point using ex-
tracts prepared from cells coinfected with vaccinia virus
strains VTF7.5 and VMM5.2. Western blotting with the
monoclonal antibody detected a recombinant sfvSOD
protein exhibiting a mass of 18 kDa in cell extracts
treated with sodium dodecyl sulfate and -mercapto-
ethanol, whereas a predominant species exhibiting a
mass closer to 35 kDa was detected in unreduced
extracts (Fig. 6, lanes 1 and 3). MyxSOD exhibited iden-
tical behavior in BGMK cell extracts as did purified sfv-
SOD expressed in E. coli (data not shown). Disulfide
bonds can oxidize during protein extraction, so we re-
peated the experiment adding 40 mM N-ethyl maleimide
to all of the extraction and gel loading buffers. This
treatment alkylates free sulfhydryl residues and indeed
prevented formation of dimers and higher order com-
plexes (Fig. 6, lane 2). These experiments show that
unlike cellular Cu-Zn SODs, which bear intrastrand di-
sulfide bonds (Tainer et al., 1982), Leporipoxviral proteins
can form homodimers linked in solution by interstrand
disulfide bonds. However, formation of dimers and other
complexes requires more oxidizing conditions than
those found in the cytoplasm of infected cells.
Effect of virus infection on cellular Cu-Zn SOD activity
As indicated previously, a number of experiments were
performed looking for novel superoxide dismutase activ-
ities induced during the course of SFV or myxoma infec-
tion and all without success. Rather, virus infection
clearly caused a time-dependent reduction in the activity
of endogenous Cu-Zn SOD. The results of one such
experiment are shown in Fig. 7. Cells infected with SFV
at a multiplicity of infection of 10 exhibited a 60% reduc-
tion in Cu-Zn SOD levels over a 40-h time period as
determined using an in situ gel assay. The effect was
very reproducible, being observed three times in three
independent experiments.
These experiments cannot differentiate gene-specific
effects from the nonspecific effects that might be caused
by virus inhibition of cellular gene expression, so we
repeated the experiments using MYX_131R virus. A
more direct and quantitative spectrophotometric assay
was used for these experiments, one that monitors SOD
interference in the autoxidation of 6-hydroxydopamine
(Heikkila, 1985). We also extracted the samples with
chloroform and methanol to remove Fe and Mn SOD and
thus to ensure the assay detects only Cu Zn SOD. The
results of one such experiment are shown in Fig. 8. This
spectrophotometric assay confirmed the gel-based data
(Fig. 7), with SFV infections causing an 60% reduction
in Cu-Zn SOD activity over 42 h in both experiments. A
similar reduction in SOD activity was also seen in myx-
oma-infected cells and in cells infected with recombinant
vaccinia viruses expressing S131R. In the latter case it is
noteworthy that the vaccinia virus expression vectors
probably express 10- to 100-fold more protein than is
produced by wild-type SFV or myxoma viruses and sug-
gests that M/S131R protein concentrations probably do
not limit the rate of inhibition of cellular SOD in ordinary
infections. Most importantly, little change in Cu-Zn SOD
FIG. 7. Cellular Cu-Zn SOD activity declines during SFV infection.
SIRC cells were infected (or mock infected) with SFV at a multiplicity of
infection of 10 and the infection terminated by freezing the cells at the
time points indicated. Proteins were recovered and extracted with
chloroform and ethanol and 30 g of protein applied to each lane of a
native polyacrylamide gel. After electrophoresis, Cu-Zn SOD activity
was detected by in situ staining (see Materials and Methods). Two
major isoforms of rabbit cellular Cu-Zn SOD were detected in these
assays, while at least three major Cu-Zn SOD isoforms are seen in this
preparation of commercial bovine control protein (right-most lanes).
Densitometry (using NIH Image1.6.1) showed that the combined activity
of both rabbit isoforms declined nearly 60% over the course of 42 h in
SFV-infected cells, relative to the amount of Cu-Zn SOD activity de-
tected at parallel time points in mock-infected cells.
FIG. 6. SfvSOD can form disulfide cross-linked dimers. Proteins were
extracted 24 h postinfection from SIRC cells infected with VMM5.2 plus
VTF7.5 at a multiplicity of infection of 20. Protein samples were ex-
tracted by boiling in a loading buffer containing 2% sodium dodecyl
sulfate with or without 2% -mercaptoethanol, separated by SDS–
PAGE, and Western blotted using an anti-sfvSOD monoclonal antibody.
In the absence of reducing agent, the sfvSOD protein forms variable
amounts of aggregates with a prominent species migrating as a 34.5-
kDa dimer (lane 3). This is halved to about 18 kDa by -mercaptoetha-
nol treatment (lane 1). When proteins were extracted in the presence of
40 mM N-ethylmaleimide, alkylation of free sulfhydryl groups similarly
prevented formation of high molecular weight complexes (lane 2).
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activity was seen in MYX_131R-infected cells, relative
to mock-infected cells, until very late in infection and at
about the time where significant cytopathic effects start
to be seen. We concluded that although the Leporipox-
virus M131R and S131R gene products lack any dis-
mutase activity, a reduction in the activity of cellular
Cu-Zn SOD accompanies their expression.
Virulence of MYX_131R in European rabbits
To examine the role of the M131R gene product in virus
pathogenicity, six rabbits were inoculated with the
MYX_131R virus and the clinical manifestations were
compared with infections caused by the parental virus
strain Lausanne. We examined such disease features as
the primary lesion, secondary lesions, secondary bacte-
rial infections, and disease outcome. The results of this
study are summarized in Table 1. M131R-deleted viruses
caused a form of myxomatosis disease very similar to
that caused by wild-type viruses. However, two modest
differences seemed worthy of note. First, MYX_131R
caused a primary lesion that appeared 1 day later than
did lesions caused by the parental virus (day 3 vs day 2
postinoculation), and the growth of these primary lesions
lagged behind those produced by wild-type viruses. Sec-
ond, MYX_131R viruses did not spread quite so effec-
tively to form the localized tumor-like nodules, which
characterize the secondary lesions seen in wild-type
infections. Instead, the ears of rabbits infected with the
mutant virus bore lesions exhibiting a more generalized
inflamed appearance. Although these observations sug-
gest that mutating M131R affects lesion morphology, it
was clear that deleting the gene in no way affects the
profound immunosuppression and subsequent bactere-
mia so characteristic of myxomatosis (Kerr and Best,
1998; Nash et al., 1999). All animals showed evidence of
secondary bacterial infection by 6 days postinfection and
all had to be euthanized by days 10 or 11 due to the
severity of the symptoms. Postmortem examination of the
internal tissues, including various lymph nodes, detected
showed no significant differences in gross pathology.
DISCUSSION
Several poxvirus-encoded proteins could potentially
alter the redox state of infected cells. However, only in
the case of genes such as vaccinia virus G4L and O2L is
the link between enzymatic function and virus biology
reasonably well understood. In this article, we describe
the characterization of another class of potentially redox-
active poxvirus proteins, the S131R and M131R Cu-Zn
SOD homologs encoded by Leporipoxviruses. Synthesis
of these proteins leads to a reduction in the activity of
FIG. 8. Changes in cellular Cu-Zn SOD activity monitored by hydroxy-
dopamine assays. SIRC cells were infected with the indicated viruses
at a multiplicity of infection of 10 and Cu-Zn SOD activity assayed
spectrophotometrically as described under Materials and Methods.
The amount of SOD activity in infected cells was normalized relative to
the amount detected in mock-infected cells at each time point, and
each measurement was determined in triplicate. The absolute amount
of SOD activity measured in mock-infected cells ranged from 14 U/mg
at time t  0 h to 16 U/mg at time t  42 h.
TABLE 1
Pathogenicity of M131R-Deficient Viruses in European Rabbits
Feature
Phenotype and timing (days postinoculation)
Myxoma virus (MYX_131R)a Myxoma virus (wild-type)b
Primary lesion Day 3: First appearance. Day 2: First appearance.
Day 4: Diameter 1–1.5 cm. Day 4: Diameter 3 cm with multiple satellite lesions
surrounding inoculation site.
Secondary lesions Day 6: First appearance. Day 5: Multiple secondary lesions (nodules) on ears, nose,
and eyelids.Day 7: Generalized ear inflammation more evident.
Bacteremia Day 6: First appearance, heavy discharge from
nose and eyes, labored breathing.
Day 6: First appearance, heavy discharge from nose and eyes,
labored breathing.
Termination Days 10 and 11: Euthanized due to difficulties
eating, drinking, and breathing.
Days 10 and 11: Euthanized due to difficulties eating, drinking,
and breathing.
a Six rabbits, 3000 PFU intradermally.
b Two rabbits, 3000 PFU intradermally.
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their cellular homolog in vivo, but what advantage is
gained by the virus is something that requires further
investigation.
Comparison of the amino acid sequences of SFV and
myxoma SOD homologs with the sequence and structure
of catalytically active bovine cupro-zinc superoxide dis-
mutase provides several possible reasons for the lack of
enzymatic activity. In particular an R-to-V substitution
would be expected to severely reduce the rate of catal-
ysis by preventing the interactions that stabilize super-
oxide anion within the active site (V154 in M/S131R ap-
pears to replace R142 in bovine Cu-Zn SOD). A further
reduction in activity might be expected from the substi-
tution of T136 and H45 in bovine SOD by H148 and N59 in
M/S131R, respectively. These substitutions result in the
transposition of a Cu-coordinating histidine residue
across the Cu binding cleft to a position that might well
interfere with superoxide gaining access to the metal.
Molecular modeling also provides an explanation for
why these proteins can form dimers linked by interstrand
disulfide bonds (Fig. 6). The ability to form intrastrand
disulfide bonds, as seen in the bovine SOD protein
structure, would be blocked in the viral proteins by a
C-to-W157 substitution near the M/S131R C-termini (Fig. 1).
Instead, this mutation, plus a small deletion located near
M/S131R residue C67 in one protein subunit, would place
C67 within cross-linking distance of a highly conserved
cysteine on the second chain (C21 in M131R and S131R,
C7 in bovine SOD). Symmetry considerations suggest
that two chains could be held together as dimers by two
such interstrand disulfide bonds, although data pre-
sented in Fig. 6 suggest that other heterologous disulfide
bonding arrangements are possible. Collectively these
mutations readily explain the observed biochemical
properties of Leporipoxvirus SOD homologs, but they
leave unanswered the intriguing question of why the
proteins have conserved all of the Zn and Cu binding
residues. In this regard these proteins are different from
Orthopoxvirus SOD homologs, where substitutions and
deletions have eliminated the Zn-binding domain (Fig. 1),
rearranged the cysteines so that interstrand cross-links
do not form, and radically altered other portions of the
protein.
Expression studies showed that Leporipoxvirus SOD
homologs resemble their Orthopoxvirus homologs in be-
ing expressed late in infection and packaged into virions.
We estimated that 1400 molecules of myxSOD are
packaged per virion and, although Almazan et al. did not
try to quantitate the amounts of A45R protein packaged
in their studies, the efficiency of immunogold labeling is
consistent with it also being an abundant vaccinia cap-
sid protein (Almazan et al., 2001). Under these circum-
stances it is thus surprising that M/S131R, similar to
A45R, is not required for growth in culture. In fact
MYX_131R virus grew to 10-fold higher titers than did
wild-type virus under conditions involving either a multi-
plicity of infection of 10 (Fig. 3) or following plating at a
multiplicity of infection of 0.001 (data not shown). Since
earlier studies showed that insertion and expression of
the gpt gene in myxoma M001R/L had no effect on virus
replication in BGMK and RK13 cells (Lalani et al., 1999),
we must conclude that this change in phenotype is due
to deletion of M131R rather than the expression of a
selection marker. In this regard myxoma virus behaves
differently from vaccinia virus as deleting A45R has no
obvious effects on viral growth. One explanation might
be that this selection pressure long ago introduced ad-
vantageous deletion mutation(s) into Orthopoxviral A45R
homologs and that deleting the rest of the gene gains
vaccinia no further growth advantages.
Why a virus lacking an abundant capsid protein would
grow better than the wild-type parent remains a mystery.
Nor is it clear whether, or how, this phenotype relates to
the associated reduction in endogenous Cu-Zn SOD ac-
tivity (Figs. 7 and 8). One possible explanation concerns
a hypothetical competition for intracellular Cu and/or Zn.
Poxviral SOD homologs conserve the interfacial amino
acid residues that play an important role in docking
Cu-Zn SOD monomers to cellular copper chaperones.
Slow inhibition of cellular Cu-Zn SOD might result, were
the viral protein to compete successfully with the cellular
homolog for binding to the chaperone and prevent
proper addition of metals to an accumulating apo-pro-
tein. Second, Zn is a cofactor in many proteins, including
the transcription machinery, and may play a role in reg-
ulating apoptosis (Chai et al., 1999). Viral SOD homologs
might sequester sufficient amounts of metal to modulate
such Zn-dependent processes. [In this regard it is nota-
ble that A45R protein lacks most of the amino acids
involved in Zn binding (Fig. 1) and so a model involving
competition for Zn could also explain why deleting A45R
had no effect on vaccinia growth.] Finally, SOD homologs
might inhibit cellular SOD activity through formation of
inhibitory complexes. We have modeled such het-
erodimers and seen no reason why they could not form,
but have yet to demonstrate heterodimer formation ex-
perimentally. It is also not obvious why complex forma-
tion should inhibit the functional subunit. Any of these
schemes would, of course, require a lot of protein. This
may not be an issue given the amount of viral SOD that
could be exposed to the cytoplasm following uncoating
or which is synthesized late in infection. We noted that
cellular SOD activity levels start to decline before the
onset of late gene expression (Figs. 7 and 8), and this
process may reflect the impact of virion-associated pro-
teins released during virus uncoating.
Although the MYX_131R virus grew better in culture
than did the wild-type virus, this phenotype was not
reflected in any change in virulence in rabbits. Both
viruses caused nearly identical disease courses and
mortality, with a only modest difference noted being a
slight delay in the rate of initial disease progression in
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MYX_131R-infected animals (Table 1). A similar lack of
effect, associated with deleting A45R from vaccinia virus,
was also noted previously using mouse and rabbit infec-
tion models (Almazan et al., 2001).
In sum, the data presented here show that the prop-
erties of SFV and myxoma M/S131R gene products, sim-
ilar to vaccinia A45R protein, are paradoxical. These
proteins are incorporated in large amounts into virus
particles, although they are clearly not essential for virus
viability and deletion mutations have no apparent effect
on virulence in animals. We are left to speculate that
these proteins may play a role in virus transmission,
perhaps protecting virions from natural environmental
insults not encountered in laboratories. Alternatively they
may serve a function required in Sylvilagus rabbits that is
masked by the virulent disease observed in Oryctolagus
species. Clearly, novel experimental protocols will be
required to confirm or refute this hypothesis.
MATERIALS AND METHODS
Cells, viruses, and virus culture
Baby green monkey kidney, rabbit kidney, and rabbit
corneal fibroblast cells were grown in Dulbecco’s mod-
ified Eagle’s media (DMEM) supplemented with 5% fetal
bovine serum as previously described (Parks and Evans,
1991). Myxoma virus strain Lausanne, SFV strain Kasza,
and vaccinia virus strain Western Reserve (WR) were
obtained from the American Type Culture Collection.
Vaccinia strain VTF7.5 encodes T7 phage RNA polymer-
ase and was obtained from Dr. B. Moss (NIH). Myxoma
strain MYXlac was described previously and encodes
the E. coli lacZ gene inserted at the intergenic locus
between the myxoma growth factor gene and M009L
(Opgenorth et al., 1992). MYXlac virions were purified by
sedimentation through tartrate gradients (Willer et al.,
1999), except that infected cells were extracted by both
sonication and Dounce homogenization and banded par-
ticles were dialyzed to remove the gradient buffer.
Growth curve analysis employed monolayers of BGMK
and RK13 cells (5  105 in a 3.5-cm dish) infected with
5 106 virus PFU of virus in 200 L of growth medium.
After incubation at 37°C for 1 h, the cells were washed
with phosphate-buffered saline (PBS) and the media re-
placed. The infection was stopped by transferring the
dish to 80°C, at the time points indicated (Fig. 3), and
the virus was harvested using three rounds of freeze and
thaw, followed by centrifugation at 1500 g for 10 min.
Appropriate dilutions of this supernatant were plated on
near-confluent monolayers of BGMK or RK13 cells, cul-
tured 3 days, fixed with 3.7% formaldehyde at room tem-
perature, stained with 0.5% crystal violet for 1 min, and
counted.
Protein labeling experiments employed monolayers of
SIRC cells cultured in DMEM and 5% fetal calf serum.
Following virus infection, the media was replaced with
cysteine–methionine-depleted DMEM (Gibco) supple-
mented with 5% dialyzed fetal bovine serum. Two hours
prior to harvest, 200 Ci of 35S-labeled cysteine–methi-
onine mix was added per 106 cells (ICN). The cells were
harvested by washing twice with PBS and then scraped
into 500 L of RIPA lysis buffer. After fractionating the
proteins by SDS–PAGE, the gel was stained with Coo-
massie dye, destained, dried, and exposed to X-OMAT-AR
(Kodak) film.
Deletion of M131R
Myxoma strain MYX_131R was constructed using
homologous recombination (Fig. 2). The targeting plas-
mid, pJXC100, was constructed by PCR amplifying 542 bp
DNA located upstream of M131R [primers M131R-FLF
(5-ATCTCGAGTGCGTATATTATACACGGCC-3) and M131R-
FLR (5-GGGATATCCATTTATAGTATTACTAAACG-3)] plus
509 bp downstream [primers M131R-FRF (5-GGACTAGT-
TAAATAACCTCGCTAAAATG-3) and M131R-FRR (5-TA-
GAGCTCGGGAATCTACTCTACTGTT-3)], and then by in-
serting these fragments into EcoRV/XhoI and SpeI/SacI
sites in pBluescript KS. A cassette encoding the E. coli
gpt gene driven by a vaccinia early/late p7.5 promoter
(Falkner and Moss, 1988) was subsequently inserted at
the SmaI site. DNA sequencing confirmed the absence
of PCR-induced mutations. Plasmid pJXC100 was trans-
fected into BGMK cells infected with wild-type myxoma
virus, strain Lausanne, and strain MYX_131R isolated
using three rounds of blind passage in the presence of
mycophenolic acid (25 g/mL) followed by three rounds
of plaque purification without selection.
Cloning and purification of recombinant S131R
The PCR and two primers [sSOD5 (5-AAGCTTAG-
GATCCATGAATAATAGAGCGTG-3) and sSOD3 (5-AA-
GAATTCTTAAGCAACTCCTATAATC-3)] were used to am-
plify a 500-bp DNA fragment encoding the S131R open
reading frame. The PCR product was cloned using a
pCR2.1 Topo cloning kit (Invitrogen), sequenced, and
recloned in BamHI/EcoRI-cut pGEX2T vector producing
pDE422. The recombinant fusion protein was extracted
from E. coli strain DH5/pDE422 following isopropyl--
D-galactopyranoside induction and affinity purified using
a glutathione resin as directed by the suppliers of these
reagents (Pharmacia). The fusion protein was treated
with human thrombin (1 cleavage unit of thrombin per
100 g protein, Sigma) to release the sfvSOD domain.
Recombinant sfvSOD was also produced using a hy-
brid vaccinia virus-T7 RNA polymerase expression sys-
tem (Fuerst et al., 1987). The PCR and two primers
[sSOD/NcoI (5-CCATGGATAATAGAGCGTGTC-3) and
sSOD 3 (above)] were used to amplify a 500-bp DNA
fragment encoding the S131R open reading frame. The
PCR product was cloned using a pCR2.1 Topo cloning kit
(Invitrogen), sequenced, and recloned into NcoI and XhoI
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sites in a pTM3 targeting vector, producing pMM103.
pMM103 was transfected into vaccinia virus-infected
cells, and recombinant isolates recovered using myco-
phenolic acid (25 g/mL), xanthine (250 g/mL), and
hypoxanthine (15 g/mL) selection. The structure of pu-
tative recombinants was confirmed by Southern blotting.
SfvSOD expression was obtained by coinfecting BSC-40
cells with recombinant viruses (VMM1.5 or VMM5.2) plus
VTF7.5 at a multiplicity of infection of 2 of each virus.
Monoclonal antibody preparation
Recombinant sfvSOD fusion protein was purified from
E. coli and 4  30 g injections used to immunize
BALB/c mice over a 2-week period (Spitz et al., 1984).
Spleen cells were recovered, fused to SP2/0 myeloma
cells using polyethylene glycol, and hybridoma lines iso-
lated using RPMI selection media containing 20% fetal
bovine serum plus hypoxanthine, aminopterin, and thy-
midine (Kohler and Milstein, 1975). Clone P115.27.R2 was
shown, using enzyme-linked immunosorbent assays and
Western blots, to produce antibodies that strongly re-
acted with sfvSOD but not glutathione-S-transferase. It
was subcloned twice by the method of limiting dilution
and then stored frozen in liquid nitrogen. Antibodies
were subsequently purified from serum-free culture su-
pernatants by protein G affinity chromatography (Bio-
Rad). Several cell lines, producing antibodies which rec-
ognized the GST fusion partner, were also identified in
this screen. One (P115.21.R2) was retained as a source of
GST-specific IgG.
Cu-Zn SOD assays
In situ gel assays utilized the method of Beauchamp
and Fridovich (1971). However, in experiments designed
to detect sfvSOD and myxSOD activity, we omitted the
chloroform/ethanol extraction step because it is uncer-
tain whether viral SOD homologs, such as cellular Cu-Zn
SOD, would resist this treatment. This step was retained
in spectrophotometric experiments designed to detect
changes in cellular Cu-Zn SOD activity, because it re-
moves Mn and Fe SOD. SIRC or BGMK cell monolayers
were infected with virus at a multiplicity of infection of 10
and then harvested with a plastic scraper in a buffer
containing 39 mM Na2HPO4, 11 mM NaH2PO4, 0.1 mM
EDTA, pH 7.4. After sonication and clarification by cen-
trifugation at 16,000 g, the protein concentration was
determined using a Bradford dye (Bio-Rad), 30 g of
protein was mixed with 1 vol 2 loading buffer (without
sodium dodecyl sulfate or reducing agent), and then
fractionated by electrophoresis on a 10% native poly-
acrylamide gel. SOD activity was detected by soaking
the gel in a solution containing 2.5 mM nitroblue tetra-
zolium (Sigma) for 20 min at 20°C, followed by soaking
15 min in a solution containing 28 mM tetramethylethyl-
enediamine (Bio-Rad), 28 M riboflavin (Sigma), and 36
mM potassium phosphate, pH 7.8. The gel was then
exposed to bright white light on a transilluminator for 20
min. The stain was replaced with water and the exposure
continued until maximal contrast was obtained between
the achromatic zone, marking SOD activity, and the blue
background (1 h). Positive controls used commercial
bovine Cu-Zn SOD (Sigma).
Spectrophotometric assays measured SOD interfer-
ence in the reduction of 6-hydroxydopamine (Heikkila,
1985). Briefly, 60 g of sample was added to 0.45 mL of
50 mM sodium phosphate, 0.1 mM EDTA, pH 7.4 in a
spectrophotometer cuvette equilibrated at 37°C, and the
reaction started by adding 5 L of 10 mM 6-hydroxydo-
pamine hydrobromide (ICN). The sample was mixed
quickly and the rate of change of the absorbance mon-
itored for 30 s at 490 nm.
SDS–PAGE and Western blot analysis
SDS–PAGE (12%) was performed as described previ-
ously (Zhang and Evans, 1993) and the proteins then
electrophoretically transferred to a PVDF membrane
(Millipore). In some experiments N-ethylmaleimide
(Sigma) was added to a final concentration of 40 mM in
all extraction and loading buffers (White et al., 2002). The
membrane was blocked overnight at 4°C in PBST (phos-
phate-buffered saline containing 0.1% Tween) and 5%
blocking agent (Amersham) and then incubated with
1:1000 diluted monoclonal antibody for 1 h at 20°C. After
six washes with PBST buffer, the membrane was probed
with 1:20,000 diluted horseradish peroxidase conjugated
anti-mouse IgG (Bio-Rad), washed again six times with
PBST, and immunoreactive material detected using a
chemiluminescent detection kit (Pierce).
Electron microscopy
A suspension of 200-nm-diameter polystyrene beads
(109 particles/mL, Duke Scientific) was diluted 1:10 with a
sample of gradient purified and dialyzed virus particles,
applied to the surface of a 200-mesh Formvar-coated
copper grid and negatively stained with 1.5% uranyl ac-
etate. The sample was imaged with a LEO 912AB micro-
scope, imaged digitally, and11,000 magnification prints
prepared showing random fields of virus and beads. The
ratio of beads to virus particles, in conjunction with the
bead concentration, provided an estimate of virus titer.
Pathogenesis studies
The experimental procedure was essentially identical
to one previously described (Lalani et al., 1999), except
that each rabbit was injected with 3000 PFU of virus.
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